Search for: "ASSOCIATION FOR MOLECULAR V PTO" Results 21 - 40 of 54
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Dec 2011, 6:42 am by Matt Osenga
Association for Molecular Pathology v. [read post]
14 Nov 2012, 2:06 pm by Antoinette Konski
(“Respondent” or “Myriad”) filed its brief in opposition to Petitioners’ (The Association for Molecular Pathology et al., represented by the American Civil Liberties Union or “ACLU”) quest for U.S. [read post]
11 May 2011, 5:28 pm by Michael O'Brien
Orlofsky could find that cut the other way was Molecular Diagnostics Labs. v. [read post]
13 Jun 2013, 12:05 pm by Kevin Miles
The full decision is located here, but the holding is below.http://www.supremecourt.gov/opinions/12pdf/12-398_8njq.pdf ASSOCIATION FOR MOLECULAR PATHOLOGY ET AL. v.MYRIAD GENETICS, INC., ET AL. [read post]
29 Mar 2010, 5:08 pm by Joe Mullin
 The full name of the case is Association for Molecular Pathology et al. v. [read post]
1 Aug 2019, 7:46 am by Jason Rantanen
I am also in the perhaps much smaller camp that is skeptical of the approach adopted by the Court in its Association for Molecular Pathology v. [read post]
13 May 2009, 8:00 pm
The lawsuit, Association for Molecular Pathology, et al. v. [read post]
4 Mar 2014, 2:01 pm by Dennis Crouch
The updated guidance is necessary based upon the Supreme Court’s decisions in Association for Molecular Pathology v. [read post]
3 Nov 2009, 10:48 am
” The lawsuit, Association for Molecular Pathology, et al. v. [read post]
31 Jul 2011, 9:28 pm
The Association For Molecular Pathology et al v. [read post]
18 Jun 2013, 12:04 am by Prashant Reddy
”[5]In a unanimous opinion in Association for Molecular Pathology, et al., v. [read post]
7 Sep 2010, 6:10 pm by Kelly
(Spicy IP) Evergreen or nevergreen: that is the question – Coversyl (Perindopril); Diovan (Valsartan) (IPKat) Australia: Senate enquiry into gene patents put on hold (Patentology) Australia: Gene patents feature on Australian ‘Four Corners’ tv program (Patentology) (Patentology) China: The basics on China Pharma, Part 3: Mistakes to be avoided (China Law Blog) India: NCE’s outside the scope of Sec. 3(d), efficacy data not required (Patent Circle) India: WSJ criticises DCGI… [read post]
1 Apr 2010, 3:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: District Court S D New York: ‘Isolated DNA’ patents fail to claim patentable subject matter: Association for Molecular Pathology and ACLU v. [read post]